Structure and biological activity of polyether ionophores and their semisynthetic derivatives

Bioactive Natural Products: Chemistry and Biology

Volumn , Issue , 2015, Pages 107-170

  Antoszczak, Michał ^a   Rutkowski, Jacek ^a   Huczyński, Adam ^a  

^a ADAM MICKIEWICZ UNIVERSITY   (Poland)

Author keywords

Antibacterial activity; Anticancer activity; Antifungal activity; Antiparasitic activity; Antiviral activity; Chemical modification; Complexes; Lasalocid acid; Monensin; Polyether ionophores; Salinomycin

Indexed keywords

BIOACTIVITY; CHEMICAL MODIFICATION; DISEASES; ETHERS; STEM CELLS;

ANTI-BACTERIAL ACTIVITY; ANTI-FUNGAL ACTIVITY; ANTICANCER ACTIVITIES; ANTIPARASITIC ACTIVITY; ANTIVIRAL ACTIVITIES; COMPLEXES; LASALOCID; MONENSIN; POLYETHER IONOPHORES; SALINOMYCIN;

IONOPHORES;

EID: 84937767100     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1002/9783527684403.ch6     Document Type: Chapter

References (257)

1. Dutton, C.J., Banks, B.J., and Cooper, C.B. (1995) Polyether ionophores. Nat. Prod. Rep., 12, 161-185.
2. Callawy, T.R., Edringto, T.S., Rychlik, J.L., Genovese, K.J., Poole, T.L., Jung, Y.S., Bischoff, K.M., Anderson, R.C., and Nisbet, D.J. (2003) Ionophores:their use as ruminant growth promotants and impact on food safety. Curr. Issues Intest. Microbiol., 4, 43-51.
3. Rutkowski, J. and Brzezinski, B. (2013) Structures and properties of naturally occurring polyether antibiotics. Biomed. Res. Int., 2013, Article ID 162513.
4. Rochefeuille, S., Jimenez, C., Tingry, S., Seta, P., and Desfours, J.P. (2002) Mixed Langmuir-Blodgett monolayers containing carboxylic ionophores. Application to Na+ and Ca2+ ISFETbased sensors. Mater. Sci. Eng., C, 21, 43-46.
5. Gabrielli, C., Hemery, P., Letellier, P., Masure, M., Perrot, H., Rahmi, M.I., and Turmine, M. (2004) Investigation of ion-selective electrodes with neutral ionophores and ionic sites by EIS. II. Application to K+ detection. J. Electroanal. Chem., 570, 291-304.
6. Graven, S.N. and Lardy, H.A. (1966) Alkali metal cation release and respiratory inhibition induced by nigericin in rat liver mitochondria. Proc. Natl. Acad. Sci. U.S.A., 56, 654-658.
7. Steinrauf, L.K., Pinkerton, M., and Chamberlin, J.W. (1968) The structure of nigericin. Biochem. Biophys. Res. Commun., 33, 29-31.
8. Gachon, P. and Kergomard, A. (1975) Grisorixin, an ionophorous antibiotic of the nigericin group. Fermentation, isolation, biological properties and structure. J. Antibiot., 28, 345-350.
9. Alleaume, M. and Hickel, D. (1970) The crystal structure of grisorixin silver salt. J. Chem. Soc., D: Chem. Commun., 21, 1422-1423.
10. Alleaume, M. and Hickel, D. (1972) Crystal structure of the thallium salt of the antibiotic grisorixin. J. Chem. Soc., D: Chem. Commun., 3, 175-176.
11. Omura, S., Shibata, M., Machida, S., Sawada, J., and Otake, N. (1975) Isolation of a new polyether antibiotic, lonomycin. J. Antibiot., 29, 15-20.
12. Otake, N., Koenuma, M., Miyamae, H., Sato, S., and Saito, Y. (1975) Studies on the ionophorous antibiotics. Part III. The structure of lonomycin, a polyether antibiotic. Tetrahedron Lett., 16, 4147-4150.
13. Fehr, T., King, H.D., and Kuhn, M. (1977) Mutalomycin, a new polyether antibiotic. Taxonomy, fermentation, isolation and characterization. J. Antibiot., 30, 903-907.
14. Fehr, T., Kuhn, M., Loosil, H.R., Ponelle, M., Boelsterli, J.J., and Walkinshaw, M.D. (1989) 2-Epimutalomycin and 28-epimutalomycin, two new polyether antibiotics from Streptomyces mutabilis. Derivatization of mutalomycin and the structure elucidation of two minor metabolites. J. Antibiot., 42, 897-902.
15. Jones, N.D., Chaney, M.O., Chamberlin, J.W., Hamill, R.L., and Chen, S. (1973) Structure of A-204A, a new polyether antibiotic. J. Am. Chem. Soc., 95, 3399-3400.
16. Imada, A., Nozaki, Y., Hasegawa, T., Mizuta, E., Igarasi, S., and Yoneda, M. (1977) Carriomycin, a new polyether antibiotic produced by streptomyces hygroscopicus. J. Antibiot., 31, 7-14.
17. Nakayama, H., Otake, N., Miyamae, H., Sato, S., and Saito, Y. (1979) Studies on the ionophorous antibiotics. Part 14. Crystal and molecular structure of the thallium salt of carriomycin. J. Chem. Soc., Perkin Trans. 2, 3, 293-295.
18. Keller-Juslen, C., King, H.D., Kis, Z.L., and von Wartburg, A. (1975) Septamycin, a polyether antibiotic. Taxonomy, Fermentation, isolation and characterization. J. Antibiot., 27, 854-859.
19. Rodios, N.A. and Anteunis, M.J.A. (1978) Solution conformation of septamycin and its sodium salt. J. Antibiot., 31, 294-301.
20. Tsuji, N., Nagashima, K., Kobayashi, M., Wakisaka, Y., Kawamura, Y., Kozuki, S., and Mayama, M. (1976) Two new antibiotics, A 218 and K 41 isolation and characterization. J. Antibiot., 29, 10-14.
21. Shiro, M., Nakai, H., Nagashima, K., and Tsuji, N. (1978) X-ray determination of the structure of the polyether antibiotic K-41. J. Chem. Soc., Chem. Commun., 16, 682-683.
22. Otoguro, K., Ishiyama, A., Ui, H., Kobayashi, M., Manabe, C., Yan, G., Takahashi, Y., Tanaka, H., Yamada, H., and Omura, S. (2002) In vitro and in vivo antimalarial activities of the monoglycoside polyether antibiotic, K-41 against drug resistant strains of Plasmodia. J. Antibiot., 55, 832-834.
23. Kusakabe, Y., Mitsuoka, S., Omuro, Y., and Seino, A. (1980) Antibiotic No. 6016, a polyether antibiotic. J. Antibiot., 33, 1437-1442.
24. Otake, N., Ogita, T., Nakayama, H., Miyame, H., Sato, S., and Saito, Y. (1978) X-ray crystal structure of the thallium salt of antibiotic-6016, a new polyether ionophore. J. Chem. Soc., Chem. Commun., 20, 875-876.
25. Hamill, R.L., Hoehn, M.M., Pittenger, G.E., Chamberlin, J., and Gorman, M. (1969) Dianemycin, an antibiotic of the group affecting ion transport. J. Antibiot., 22, 161-164.
26. Czerwinski, E.W. and Steinrauf, L.K. (1971) Structure of the antibiotic dianemycin. Biochem. Biophys. Res. Commun., 45, 1284-1287.
27. Mizoue, K., Seto, H., Mizutani, T., Yamagishi, M., Kawashima, A., Omura, S., Ozeki, M., and Otake, N. (1980) Studiem on the ionophorous antibiotics. XXVI. The assignments of the 13C-NMR spectra of dianemycin and lenoremycin. J. Antibiot., 33, 144-156.
28. Blount, J.F., Evans, R.H., Liu, C.M., Hermann, T., and Westley, J.W. (1975) X-ray structure of Ro21-6150, a polyether antibiotic related to dianemycin. J. Chem. Soc., Chem. Commun., 943, 853-855.
29. Oscarson, J.R., Bordner, J., Celmer, W.D., Cullen, W.P., Huang, L.H., Maeda, H., Moshier, P.M., Nishiyama, S., Presseau, L., Shibakawa, R., and Tone, J. (1989) Endusamycin, a novel polycyclic ether antibiotic produced by a strain of Streptomyces endus subsp. aureus. J. Antibiot., 42, 37-48.
30. Dirlam, J.P., Presseau-Linabury, L., and Koss, D.A. (1990) The structure of CP-80,219, a new polyether antibiotic related to dianemycin. J. Antibiot., 43, 727-730.
31. Blount, J.F. and Westley, J.W. (1971) Xray crystal and molecular structure of antibiotic X-206. J. Chem. Soc., Chem. Commun., 841, 927-928.
32. Otoguro, K., Kohana, A., Manabe, C., Ishiyama, A., Ui, H., Shiomi, K., Yamada, H., and Omura, S. (2001) Potent antimalarial activities of polyether antibiotic, X-206. J. Antibiot., 54, 658-663.
33. Alleaume, M., Busetta, B., Farges, C., Gachon, P., Kergomard, A., and Staron, T. (1975) X-ray structure of alborixin, a new antibiotic ionophore. J. Chem. Soc., Chem. Commun., 11, 411-412.
34. Gachon, P., Farges, C., and Kergomard, A. (1976) Alborixin, a new antibiotic ionophore: isolation, structure, physical and chemical properties. J. Antibiot., 29, 603-610.
35. Smith, G.D. and Daux, W.L. (1976) Crystal and molecular structure of the calcium ion complex of A23187. J. Am. Chem. Soc., 98, 1578-1580.
36. Alleaume, M. and Barrans, Y. (1985) Crystal structure of the magnesium complex of calcimycin. Can. J. Chem., 63, 3482-3485.
37. Akkurt, M., Melhaoui, A., Hadda, T.B., Mimouni, M., Yildirim, S.O., and McKeec, V. (2008) Synthesis and crystal structure of the bis-calcimycin anion-Ni2+ complex. Arkivoc, 2008, 154-164.
38. Vila, S., Canet, I., Guyot, J., Jeminet, G., and Toupet, L. (2003) Unusual structure of the dimeric 4-bromocalcimycin-Zn2+ complex. J. Chem. Soc., Chem. Commun., 9, 516-517.
39. Grenier, G., Van Sande, J., Glick, D., and Dumont, J.E. (1974) Effect of ionophore A23187 on thyroid secretion. FEBS Lett., 49, 96-99.
40. Karl, B.C., Zawalich, W.S., Ferrendelli, J.A., and Matochinsky, F.M. (1975) The role of Ca2+ and cyclic adenosine 3':5'-monophosphate in insulin release induced in vitro by the divalent cation ionophore A23187. J. Biol. Chem., 250, 4575-4579.
41. Case, G.D., Vanderkooi, J.M., and Scarpa, A. (1974) Physical properties of biological membranes determined by the fluorescence of the calcium ionophore A23187. Arch. Biochem. Biophys., 162, 174-185.
42. Guoyt, J., Jeminet, G., Prudhomme, M., Sancelme, M., and Meiniel, R. (1993) Interaction of the calcium ionophore A.23187 (calcimycin) with Bacillus cereus and Escherichia coli. Lett. Appl. Microbiol., 16, 192-195.
43. David, L. and Kergomard, A. (1982) Production by controlled biosynthesis of a novel ionophore antibiotic, cezomycin (demethylamino A23187). J. Antibiot., 35, 1409-1411.
44. Westley, J.W., Liu, C.M., Blount, J.F., Sello, L.H., Troupe, N., and Miller, P.A. (1983) Isolation and characterization of a novel polyether antibiotic of the pyrrolether class, antibiotic X-14885A. J. Antibiot., 36, 1275-1278.
45. Sakurai, T., Kobayashi, K., Nakamura, G., and Isono, K. (1982) Structure of the thallium salt of cationomycin. Acta Crystallogr., Sect. B, 38, 2471-2473.
46. Ubukata, M., Hamazaki, Y., and Isono, K. (1986) Chemical modification of cationomycin and its structure-activity relationship. Agric. Biol. Chem., 50, 1153-1160.
47. Ubukata, M., Hamazaki, Y., and Isono, K. (1988) Aromatic side chain analogs of cationomycin and their biological activities. Agric. Biol. Chem., 52, 1637-1641.
48. Delort, A.M., Jeminet, G., Sareth, S., and Riddle, F.G. (1988) Ionophore properties of cationomycin in large unilamellar vesicles studied by 23Naand 39K-NMR. Chem. Pharm. Bull., 46, 1618-1620.
49. Liu, C.M. and Hermann, T.E. (1978) Characterization of ionomycin as a calcium ionophore. J. Biol. Chem., 253, 5892-5894.
50. Gao, Z., Li, Y., Cooksey, J.P., Snaddon, T.N., Schunk, S., Viseux, E.M.E., McAteer, S.M., and Kocienski, P.J. (2009) A synthesis of an ionomycin calcium complex. Angew. Chem. Int. Ed., 48, 5022-5025.
51. Liu, W.C., Smith-Slusarczyk, D., Astle, G., Trejo, W.H., Brown, W.E., and Meyers, E. (1978) Ionomycin, a new polyether antibiotic. J. Antibiot., 31, 815-819.
52. Westley, J.W., Liu, C.M., Blount, J.F., Evans, R.H., Sello, L.H., Troupe, N., and Miller, P.A. (1982) in Trends in Antibiotic Research (eds H. Umezawa et al.), Japan Antibiotics Research Association, pp. 125-134.
53. Liu, C.M., Hermann, T.E., Downey, A., Prosser, B.T., Schildknecht, E., Palleroni, H.J., Westley, J.W., and Miller, P.A. (1983) Discovery, fermentation, biological as well as ionophore properties and taxonomy of the producing culture. J. Antibiot., 36, 343-350.
54. Kusakabe, Y., Mizuno, T., Kawabata, S., Tanji, S., and Seino, A. (1982) Ferensimycins A and B, two polyether antibiotics. J. Antibiot., 35, 1119-1129.
55. Brooks, H.A., Gardner, D., Poyser, J.P., and King, T.J. (1984) The structure and absolute stereochemistry of zincophorin (antibiotic M144255): a monobasic carboxylic acid ionophore having a remarkable specificity for divalent cations. J. Antibiot., 37, 1501-1504.
56. Dirlam, J.P., Belton, A.M., Chang, S.P., Cullen, W.P., Huang, L.H., Kojima, Y., Maeda, H., Nishiyama, S., Oscarson, J.R., Sakakibara, T., Tone, J., and Yamada, M. (1989) CP-78,545, a new monocarboxylic acid ionophore antibiotic related to zincophorin and produced by a Streptomyces. J. Antibiot., 42, 1213-1220.
57. Liu, C.M., Hermann, T.E., Liu, M., Bull, D.N., Palleroni, N.J., Prosser, T., Westley, J.W., and Miller, P.A. (1979) X-14547A, a new ionophorous antibiotic produced by Streptomyces antibioticus NRRL 8167. Discovery, fermentation, biological properties and taxonomy of the producing culture. J. Antibiot., 32, 95-99.
58. Westley, J.W., Evans, R.H. Jr., Sello, L.H., Troupe, N., Liu, C.M., and Blount, J.F. (1979) Isolation and characterization of antibiotic X-14547A, a novel monocarboxylic acid ionophore produced by Streptomyces antibioticus NRRL 8167. J. Antibiot., 32, 100-107.
59. Dobler, M. (2004) in Comprehensive Supramolecular Chemistry: Molecular Recognition: Receptors for Cationic Guests, vol. 1 (ed. G.W. Gokel), Pergamon, New York, pp. 267-313.
60. Pressman, B.C. (1976) Biological applications of ionophores. Annu. Rev. Biochem., 45, 501-530.
61. Westley, J.W. (1975) Chapter 25. The polyether antibiotics: monocarboxylic acid ionophores. Annu. Rep. Med. Chem., 10, 246-256.
62. Agtarap, A., Chamberlin, J.W., Pinkerton, M., and Steinrauf, L. (1967) The structure of monensic acid, a new biologically active compound. J. Am. Chem. Soc., 89, 5737-5739.
63. Huczyński, A., Ratajczak-Sitarz, M., Katrusiak, A., and Brzezinski, B. (2007) Molecular structure of the 1:1 inclusion complex of monensin A sodium salt with acetonitrile. J. Mol. Struct., 832, 84-89.
64. Huczyński, A., Janczak, J., Łowicki, D., and Brzezinski, B. (2012) Monensin a acid complexes as a model of electrogenic transport of sodium cation. Biochim. Biophys. Acta, Biomembr., 1818, 2108-2119.
65. Huczyński, A., Ratajczak-Sitarz, M., Katrusiak, A., and Brzezinski, B. (2007) Molecular structure of the 1:1 inclusion complex of monensin A lithium salt with acetonitrile. J. Mol. Struct., 871, 92-97.
66. Huczyński, A., Ratajczak-Sitarz, M., Katrusiak, A., and Brzezinski, B. (2008) Molecular structure of rubidium six-coordinated dihydrate complex with monensin A. J. Mol. Struct., 888, 224-229.
67. Pantcheva, I.N., Zhorova, R., Mitewa, M., Simova, S., Mayer-Figge, H., and Sheldrick, W.S. (2010) First solid state alkaline-earth complexes of monensic acid A (MonH): crystal structure of [M(Mon)2(H2O)2] (M=Mg, Ca), spectral properties and cytotoxicity against aerobic Gram-positive bacteria. Biometals, 23, 59-70.
68. Pantcheva, I.N., Ivanova, J., Zhorova, R., Mitewa, M., Simova, S., Mayer-Figge, H., and Sheldrick, W.S. (2010) Nickel(II) and zinc(II) dimonensinates. Single crystal X-ray structure, spectral properties and bactericidal activity. Inorg. Chim. Acta, 363, 1879-1886.
69. Dorkov, P., Pantcheva, I.N., Sheldrick, W.S., Mayer-Figge, H., Petrova, R., and Mitewa, M. (2008) Synthesis, structure and antimicrobial activity of manganese( II) and cobalt(II) complexes of the polyether ionophore antibiotic Sodium Monensin A. J. Inorg. Biochem., 102, 26-32.
70. Pantcheva, I.N., Dorkov, P., Atanasov, V.N., Mitewa, M., Shivachev, B.L., Nikolova, R.P., Mayer-Figge, H., and Sheldrick, W.S. (2009) Crystal structure and properties of the copper(II) complex of sodium monensin A. J. Inorg. Biochem., 103, 1419-1424.
71. Ivanova, J., Pantcheva, I.N., Mitewa, M., Simova, S., Mayer-Figge, H., and Sheldrick, W.S. (2010) Crystal structures and spectral properties of new Cd(II) and Hg(II) complexes of monensic acid with different coordination modes of the ligand. Cent. Eur. J. Chem., 8, 852-860.
72. Ivanova, J., Pantcheva, I.N., Mitewa, M., Simova, S., Mayer-Figge, H., and Sheldrick, W.S. (2008) First divalent metal complexes of the polyether ionophore monensin A: X-ray structures of [Co(Mon)2(H2O)2] and [Mn(Mon)2(H2O)2] and their bactericidal properties. Curr. Drug Discovery Technol., 5, 154-161.
73. Westley, J.W., Liu, C.M., Evans, R.H., Sello, L.H., Troupe, N., and Hermann, T. (1983) Preparation, properties and biological activity of natural and semisynthetic urethanes of monensin. J. Antibiot., 36, 1195-1200.
74. Huczyński, A., Ratajczak-Sitarz, M., Stefańska, J., Katrusiak, A., Brzezinski, B., and Bartl, F. (2011) Reinvestigation of the structure of monensin A phenylurethane sodium salt based on X-ray crystallographic and spectroscopic studies, and its activity against hospital strains of methicillin-resistant S. epidermidis and S. aureus. J. Antibiot., 64, 249-256.
75. Huczyński, A., Stefańska, J., Piśmienny, M., and Brzezinski, B. (2013) Spectroscopic, semiempirical studies and antibacterial activity of new urethane derivatives of natural polyether antibiotic-monensin A. J. Mol. Struct., 1034, 198-206.
76. Nakamura, A., Nagai, S., Takahashi, T., Malhan, R., Murakami, N., Ueda, T., Sakakibara, J., and Asano, M. (1992) Studies on the chemical modification of monensin. IV. Synthesis, sodium ion permeability, and biological activity of 7-O-acyl- and 7-O-alkylmonensins. Chem. Pharm. Bull., 40, 2331-2337.
77. Nagatsu, A., Takahashi, T., Isomura, M., Nagai, S., Ueda, T., Murakami, N., Sakakibara, J., and Hatano, K. (1994) Studies on chemical modification of monensin. V. Synthesis, sodium ion permeability, antibacterial activity, and crystal structure of 7-O-(4-substituted benzyl)monensins. Chem. Pharm. Bull., 42, 2269-2275.
78. Tanaka, R., Nagatsu, A., Mizukami, H., Ogihara, Y., and Sakakibara, J. (2001) Studies on chemical modification of monensin. IX. Synthesis of 26-substituted monensins and their Na+ ion transport activity. Chem. Pharm. Bull., 49, 711-715.
79. Rochdi, M., Delort, A.M., Guyot, J., Sancelme, M., Gibot, S., Gourcy, J.G., Dauphin, G., Gumila, C., Vial, H., and Jeminet, G. (1996) Ionophore properties of monensin derivatives studied on human erythrocytes by 23Na NMR and K+ and H+ potentiometry: relationship with antimicrobial and antimalarial activities. J. Med. Chem., 39, 588-595.
80. Sakakibara, J., Nakamura, A., Nagai, S.I., Ueda, T., and Ishida, T. (1988) Studies on the chemical modification of monensin. I. Synthesis and crystal structures of NaBr complexes of monensylamino acids. Chem. Pharm. Bull., 36, 4776-4784.
81. Huczyński, A., Przybylski, P., Brzezinski, B., and Bartl, F. (2006) Spectroscopic and semiempirical studies of a proton channel formed by the methyl ester of monensin A. J. Phys. Chem. B, 110, 15615-15623.
82. Huczyński, A., Przybylski, P., Brzezinski, B., and Bartl, F. (2006) Monensin A methyl ester complexes with Li+, Na+, and K+ cations studied by ESI-MS, 1H- and 13C-NMR, FT-IR, as well as PM5 semiempirical method. Biopolymers, 81, 282-294.
83. Huczyński, A., Przybylski, P., and Brzezinski, B. (2006) Complexes of monensin A methyl ester with Mg2+, Ca2+, Sr2+, Ba2+ cations studied by electrospray ionization mass spectrometry and PM5 semiempirical method. J. Mol. Struct., 788, 176-183.
84. Huczyński, A., Przybylski, P., Brzezinski, B., and Bartl, F. (2006) Spectroscopic, mass spectrometry, and semiempirical investigation of a new ester of Monensin A with ethylene glycol and its complexes with monovalent metal cations. Biopolymers, 82, 491-503.
85. Huczyński, A., Michalak, D., Przybylski, P., Brzezinski, B., and Bartl, F. (2006) Monensin A benzyl ester and its complexes with monovalent metal cations studied by spectroscopic, mass spectrometry and semiempirical methods. J. Mol. Struct., 797, 99-110.
86. Huczyński, A., Przybylski, P., and Brzezinski, B. (2007) The structures of monensin A derivatives and its complexes with some monovalent cations studied by the AM1d, PM3 as well as PM5 semiempirical methods. J. Mol. Struct., 826, 156-164.
87. Huczyński, A., Michalak, D., Przybylski, P., Brzezinski, B., and Bartl, F. (2007) Spectroscopic, mass spectrometry and semiempirical investigation of a new Monensin A allyl ester and its complexes with Li+, Na+ and K+ cations. J. Mol. Struct., 828, 130-141.
88. Huczyński, A., Przybylski, P., Schroeder, G., and Brzezinski, B. (2007) Investigation of complex structures of a new 2-hydroxyethyl ester of Monensin A with Mg2+, Ca2+, Sr2+, Ba2+ cations using electrospray ionization mass spectrometry and semiempirical PM5 methods. J. Mol. Struct., 829, 111-119.
89. Huczyński, A., Przybylski, P., and Brzezinski, B. (2007) NMR, FT-IR, ESI-MS and semiempirical study of a new 2-(2-hydroxyethoxy)ethyl ester of monensin A and its complexes with alkali metal cations. Tetrahedron, 63, 8831-8839.
90. Huczyński, A., Łowicki, D., Brzezinski, B., and Bartl, F. (2008) Spectroscopic, mass spectrometry and semiempirical investigation of a new 2-methoxyethyl ester of monensin A and its complexes with Li+, Na+ and K+ cations. J. Mol. Struct., 874, 89-100.
91. Huczyński, A., Łowicki, D., Brzezinski, B., and Bartl, F. (2008) Spectroscopic, mass spectrometry, and semiempirical investigations of a new 2-(2-methoxyethoxy)ethyl ester of Monensin A and its complexes with monovalent cations. J. Mol. Struct., 879, 14-24.
92. Huczyński, A., Stefańska, J., Przybylski, P., Brzezinski, B., and Bartl, F. (2008) Synthesis and antimicrobial properties of Monensin A esters. Bioorg. Med. Chem. Lett., 18, 2585-2589.
93. Huczyński, A., Brzezinski, B., and Bartl, F. (2008) Structures of complexes of benzyl and allyl esters of monensin A with Mg2+, Ca2+, Sr2+, Ba2+ cations studied by ESI-MS and PM5 methods. J. Mol. Struct., 886, 9-16.
94. Łowicki, D., Huczyński, A., Ratajczak-Sitarz, M., Katrusiak, A., Stefańska, J., and Brzezinski, B. (2009) Structural and antimicrobial studies of a new N-phenylamide of Monensin A complex with sodium chloride. J. Mol. Struct., 923, 53-59.
95. Łowicki, D., Huczyński, A., Stefańska, J., and Brzezinski, B. (2010) Structural characterization and antibacterial activity against clinical isolates of Staphylococcus of N-phenylamide of monensin A and its 1:1 complexes with monovalent cations. Eur. J. Med. Chem., 45, 4050-4057.
96. Łowicki, D., Huczyński, A., Stefańska, J., Brzezinski, B., and Bartl, F. (2009) Syntheses, structural and antimicrobial studies of a new N-allylamide of Monensin A and its complexes with monovalent metal cations. Tetrahedron, 65, 7730-7740.
97. Łowicki, D., Huczyński, A., and Brzezinski, B. (2011) 1H, 13C NMR, FT-IR, ESI MS as well as PM5 studies of a new 3,6,9-trioxadecylamide of monensin A and its complexes with Li+, Na+ and K+ cations. J. Mol. Struct., 990, 121-131.
98. Łowicki, D., Huczyński, A., Stefańska, J., and Brzezinski, B. (2011) Spectroscopic, semiempirical and antimicrobial studies of a new amide of monensin A with 4-aminobenzo-15-crown-5 and its complexes with Na+ cation in 1:1 and 1:2 ratios. Tetrahedron, 67, 1468-1478.
99. Huczyński, A., Łowicki, D., Ratajczak-Sitarz, M., Katrusiak, A., and Brzezinski, B. (2011) Structural investigation of a new complex of N-allylamide of Monensin A with strontium perchlorate using X-ray, FTIR, ESI MS and semiempirical methods. J. Mol. Struct., 995, 20-28.
100. Nakamura, A., Nagai, S.I., Ueda, T., Murakami, N., Sakakibara, J., Shibuya, H., and Kitagawa, I. (1991) Studies on the chemical modification of monensin. III. Synthesis and sodium ion transport activity of macrocyclic monensylamino acid-1,29-lactones. Chem. Pharm. Bull., 39, 1726-1730.
101. Huczyński, A., Janczak, J., and Brzezinski, B. (2011) Crystal structure and FT-IR study of aqualithium 1-naphthylmethyl ester of monensin A perchlorate. J. Mol. Struct., 985, 70-74.
102. Kinashi, H., Otake, N., Yonehara, H., Sato, S., and Saito, Y. (1973) The structure of salinomycin, a new member of the polyether antibiotics. Tetrahedron Lett., 49, 4955-4958.
103. Westley, J.W., Blount, J.F., Evans, R.H., and Liu, C.M. (1977) C-17 epimers of deoxy-(O-8)-salinomycin from Streptomyces albus (ATCC 21838). J. Antibiot., 30, 610-612.
104. Paulus, E.F. and Vertesy, L. (2003) Crystal structure of the antibiotic SY-1 (20-deoxy-salinomycin):sodium 2-(6-[2-(5-ethyl-5-hydroxy-6-methyl-tetrahydro-pyran-2-yl)-2,10,12-trimethyl-1, 6,8-trioxadispiro[4.1.5.3]pentadec-13-en-9-yl]-2-hydroxy-1,3-dimethyl-4-oxoheptyl-5-methyl-tetrahydro-pyran-2-yl)-butyrate - methanol solvate (1:0.69), C42H69NaO10 · 0.69CH3OH. Z. Kristallogr. New Cryst. Struct., 218, 575-577.
105. Paulus, E.F. and Vertesy, L. (2004) Crystal structure of 2-(6-[2-(5-ethyl-5-hydroxy-6-methyl-tetrahydro-pyran-2-yl)-15-oxo-2,10,12-trimethyl-1,6,8-trioxa-dispiro[4.1.5.3]pentadec-13-en-9-yl] -2-hydroxy-1,3-dimethyl-4-oxoheptyl-5-methyl-tetrahydro-pyran-2-yl)-butyrate sodium, Na(C42H67O11), SY-9 -antibiotic 20-oxo-salinomycin. Z. Kristallogr. New Cryst. Struct., 219, 184-186.
106. Mitani, M., Yamanishi, T., and Miyazaki, Y. (1975) Salinomycin: a new monovalent cation ionophore. Biochem. Biophys. Res. Commun., 66, 1231-1235.
107. Myiazaki, Y., Shibuya, M., Sugawara, H., Kawaguchi, O., Hirose, C., Nagatsu, J., and Esumi, S. (1974) Salinomycin, a new polyether antibiotic. J. Antibiot., 27, 814-821.
108. Huczyński, A., Janczak, J., Antoszczak, M., Stefańska, J., and Brzezinski, B. (2012) X-ray, FT-IR, NMR and PM5 structural studies and antibacterial activity of unexpectedly stable salinomycin-benzotriazole intermediate ester. J. Mol. Struct., 1022, 197-203.
109. Huczyński, A., Janczak, J., Stefańska, J., Antoszczak, M., and Brzezinski, B. (2012) Synthesis and antimicrobial activity of amide derivatives of polyether antibiotic - salinomycin. Bioorg. Med. Chem. Lett., 22, 4697-4702.
110. Huczyński, A., Janczak, J., Antoszczak, M., Wietrzyk, J., Maj, E., and Brzezinski, B. (2012) Antiproliferative activity of salinomycin and its derivatives. Bioorg. Med. Chem. Lett., 22, 7146-7150.
111. Antoszczak, M., Maj, E., Stefańska, J., Wietrzyk, J., Janczak, J., Brzezinski, B., and Huczyński, A. (2014) Synthesis, antiproliferative and antibacterial activity of new amides of salinomycin. Bioorg. Med. Chem. Lett., 24, 1724-1729.
112. Antoszczak, M., Popiel, K., Stefańska, J., Wietrzyk, J., Maj, E., Janczak, J., Michalska, G., Brzezinski, B., and Huczyński, A. (2014) Synthesis, cytotoxicity and antibacterial activity of new esters of polyether antibioticsalinomycin. Eur. J. Med. Chem., 76, 435-444.
113. Borgström, B., Huang, X., Pošta, M., Hegardt, C., Oredsson, S., and Strand, D. (2013) Synthetic modification of salinomycin: selective O-acylation and biological evaluation. Chem. Commun., 49, 9944-9946.
114. Berger, J., Rachlin, I.A., Scott, W.E., Sternbach, L.H., and Goldberg, M.W. (1951) The isolation of three new crystalline antibiotics from Streptomyces. J. Am. Chem. Soc., 73, 5295-5298.
115. Westley, J.W., Benz, W., Donahue, J., Evans, R.H. Jr., Scott, C.G., Stempel, A., and Berger, J. (1974) Biosynthesis of lasalocid. III Isolation and structure determination of four homologs of lasalocid A. J. Antibiot., 27, 744-753.
116. Suh, I.H., Aoki, K., and Yamazaki, H. (1989) Crystal structure of a silver salt of the antibiotic lasalocid A: a dimer having an exact 2-fold symmetry. Inorg. Chem., 28, 358-362.
117. Johnson, S.M., Herrin, J., Shiu, J.L., and Paul, I.C. (1970) Crystal structure of a barium complex of antibiotic X-537A, Ba(C34H53O8)2 ·H2O. J. Chem. Soc., Chem. Commun., 2, 72-73.
118. Akkurt, M.S., Yildirim, Ö., Khardli, F.Z., Mimouni, M., McKee, V., and Ben Hadda, T. (2008) Crystal structure of a new polymeric thallium-lasalocid complex: lasalocide anion-thallium (I) containing aryl-Tl interactions. Arkivoc, 2008, 121-132.
119. Huczyński, A., Janczak, J., Rutkowski, J., Łowicki, D., Pietruczuk, A., Stefańska, J., Brzezinski, B., and Bartl, F. (2009) Lasalocid acid as a lipophilic carrier ionophore for allylamine: spectroscopic, crystallographic and microbiological investigation. J. Mol. Struct., 936, 92-98.
120. Huczyński, A., Janczak, J., Stefańska, J., Rutkowski, J., and Brzezinski, B. (2010) X-ray, spectroscopic and antibacterial activity studies of the 1:1 complex of lasalocid acid with 1,1,3,3-tetramethylguanidine. J. Mol. Struct., 977, 51-55.
121. Huczyński, A., Pospieszny, T., Ratajczak-Sitarz, M., Katrusiak, A., and Brzezinski, B. (2008) Structural and spectroscopic studies of the 1:1 complex of lasalocid acid with 1,5,7-triazabicyclo[4.4.0]dec-5-ene. J. Mol. Struct., 875, 501-508.
122. Huczyński, A., Rutkowski, J., Wietrzyk, J., Stefańska, J., Maj, E., Ratajczak-Sitarz, M., Katrusiak, A., Brzezinski, B., and Bartl, F. (2013) X-ray crystallographic, FT-IR and NMR studies as well as anticancer and antibacterial activity of the salt formed between ionophore antibiotic lasalocid acid and amines. J. Mol. Struct., 1032, 69-77.
123. Westley, J.W., Evans, R.H., and Blount, J.F. (1977) Optical resolution of asymmetric amines by preferential crystallization as lasalocid salts. J. Am. Chem. Soc., 99, 6057-6061.
124. Westley, J.W., Oliveto, E.P., Berger, J., Evans, R.H. Jr., Glass, R., Stempel, A., Toome, V., and Williams, T. (1972) Chemical transformations of antibiotic X-537A and their effect on antibacterial activity. J. Med. Chem., 16, 397-403.
125. Pankiewicz, R., Schroeder, G., Gierczyk, B., Brzezinski, B., and Bartl, F. (2002) Multinuclear NMR and FTIR studies of new polyoxaalkyl esters of lasalocid and their complexes with lithium and sodium cations. Biopolymers, 65, 95-110.
126. Pankiewicz, R., Schroeder, G., Przybylski, P., Brzezinski, B., and Bartl, F. (2004) Lasalocid polyoxaalkyl esters complexes with Li+, Na+, K+, Rb+ and Cs+ cations studied by ESI MS and semiempirical methods. J. Mol. Struct., 688, 171-176.
127. Pankiewicz, R., Pawłowska, A., Schroeder, G., Przybylski, P., Brzezinski, B., and Bartl, F. (2004) Multinuclear NMR, FT-IR, ESI MS studies and PM5 semiempirical calculations of new ethylene glycol ester of lasalocid acid and their complexes with K+ cation. J. Mol. Struct., 694, 53-61.
128. Pankiewicz, R., Pawłowska, A., Schroeder, G., Przybylski, P., Brzezinski, B., and Bartl, F. (2004) NMR, FT-IR, ESI MS studies and PM5 semiempirical calculations of lasalocid ethylene glycol ester complexes with Li+ and Na+ cations. J. Mol. Struct., 694, 155-163.
129. Pankiewicz, R., Schroder, G., Brzezinski, B., and Bartl, F. (2004) Spectroscopic and PM5 semiempirical study of new lasalocid 5-hydroxypentyl ester and its complexes with monovalent cations. J. Mol. Struct., 699, 53-64.
130. Pankiewicz, R., Schroeder, G., and Brzezinski, B. (2005) NMR, FT-IR, ESI MS and PM5 semiempirical study of new lasalocid 5-hydroxy-3-oxapentyl ester and its complexes with monovalent cations. J. Mol. Struct., 733, 155-165.
131. Pankiewicz, R., Schroeder, G., and Brzezinski, B. (2005) Spectroscopic, spectrometric and PM5 semiempirical investigation of new lasalocid 8-hydroxy-3,6-dioxaoctyl ester and its complexes with monovalent cations. J. Mol. Struct., 733, 217-229.
132. Pankiewicz, R., Schroeder, G., Brzezinski, B., and Bartl, F. (2005) NMR, FT-IR and ESI-MS study of new lasalocid ester with 2-(hydroxymethyl)-12-crown-4 and its complexes with monovalent cations. J. Mol. Struct., 749, 128-137.
133. Pankiewicz, R., Kira, J., Schroeder, G., Ossowski, T., and Brzezinski, B. (2006) Potentiometric, ESI MS and AM1d studies of lasalocid esters-silver(I) complexes. J. Mol. Struct., 782, 63-70.
134. Pankiewicz, R., Remlein-Starosta, D., Schroeder, G., and Brzezinski, B. (2006) Biological activity and ESI MS study of oxaalkyl and hydroksyoxaalkyl lasalocid esters. J. Mol. Struct., 783, 136-144.
135. Pankiewicz, R., Schroeder, G., and Brzezinski, B. (2006) Spectroscopic and PM5 semiempirical study of a new lasalocid ester with 2-allyloxyethanol and its complexes with monovalent cations. J. Mol. Struct., 789, 1-7.
136. Pankiewicz, R., Schroeder, G., and Brzezinski, B. (2007) 1H, 13C NMR, FT-IR, ESI-MS and PM5 semiempirical study of new lasalocid ester with 3-(methylthio)-1-propanol and its complexes with monovalent cations. J. Mol. Struct., 829, 120-127.
137. Huczyński, A., Pospieszny, T., Wawrzyn, R., Ratajczak-Sitarz, M., Katrusiak, A., Brzezinski, B., and Bartl, F. (2008) Structural and spectroscopic studies of new o-, m- and p-nitrobenzyl esters of lasalocid acid. J. Mol. Struct., 877, 105-114.
138. Huczyński, A., Wawrzyn, R., Brzezinski, B., and Bartl, F. (2008) Structure of complexes of lasalocid m-nitrobenzyl ester with monovalent metal cations. J. Mol. Struct., 889, 72-80.
139. Huczyński, A., Paluch, I., Ratajczak-Sitarz, M., Katrusiak, A., Stefańska, J., Brzezinski, B., and Bartl, F. (2008) Spectroscopic studies, crystal structures and antimicrobial activities of a new lasalocid 1-naphthylmethyl ester. J. Mol. Struct., 891, 481-490.
140. Huczyński, A., Paluch, I., Ratajczak-Sitarz, M., Katrusiak, A., Brzezinski, B., and Bartl, F. (2009) Structural and spectroscopic studies of a new 2-naphthylmethyl ester of lasalocid acid. J. Mol. Struct., 918, 108-115.
141. Huczyński, A., Rutkowski, J., Brzezinski, B., and Bartl, F. (2013) Synthesis, FTIR, 1H, 13C NMR, ESI MS and PM5 studies of a new Mannich base of polyether antibiotic - lasalocid acid and its complexes with Li+, Na+ and K+ cations. Spectrochim. Acta, Part A, 104, 497-504.
142. Huczyński, A., Rutkowski, J., Borowicz, I., Wietrzyk, J., Maj, E., and Brzezinski, B. (2013) One-pot synthesis and cytotoxicity studies of new Mannich base derivatives of polyether antibiotic-lasalocid acid. Bioorg. Med. Chem. Lett., 23, 5053-5056.
143. Huczyński, A. (2012) Polyether ionophores-promising bioactive molecules for cancer therapy. Bioorg. Med. Chem. Lett., 22, 7002-7010.
144. Hildebrandt, J., Meingassner, J.G., and Mieth, H. (1978) Mode of action of the anticoccidial agent septamycine. Zentralbl. Veterinarmed. B, 25, 186-193.
145. Westley, J.W. (1982) Polyether Antibiotics:Naturally Occurring Acid Ionophores, vol. 1, Marcel Dekker Inc., New York.
146. Westley, J.W. (1983) Polyether Antibiotics:Naturally Occurring Acid Ionophores, vol. 2, Marcel Dekker Inc., New York.
147. Pressman, B.C. (1985) Antibiotics and their Complexes, vol. 1, Marcel Dekker Inc., New York.
148. Guyot, J., Jeminet, G., Prudhomme, M., Sancelme, M., and Meiniel, R. (1993) Interaction of the calcium ionophore A. 23187 (Calcimycin) with Bacillus cereus and Escherichia coli. Lett. Appl. Microbiol., 16, 192-195.
149. Westley, J.W. (1977) Polyether antibiotics: versatile carboxylic acid ionophores produced by Streptomyces. Adv. Appl. Microbiol., 22, 177-223.
150. Rafee, Y., Abdel-Haq, N., Asmar, B., Salimnia, T., Pharm, C.V., Pharm, M.J., and Amjad, M. (2012) Increased prevalence of methicillin-resistant Staphylococcus aureus nasal colonization in household contacts of children with community acquired disease. BMC Infect. Dis., 12, 45-51.
151. Mulligan, M.E., Murray-Leisure, K.A., Ribner, B.S., Standiford, H.C., John, J.F., Korvick, J.A., Kauffman, C.A., and Yu, V.L. (1993) Methicillin-resistant Staphylococcus aureus: a consensus review of the microbiology, pathogenesis, and epidemiology with implications for prevention and management. Am. J. Med., 94, 313-328.
152. Yoo, J.C., Kim, J.H., Ha, J.W., Park, N.S., Sohng, J.K., Lee, J.W., Park, S.C., Kim, M.S., and Seong, C.N. (2007) Production and biological activity of laidlomycin, anti-MRSA/VRE antibiotic from Streptomyces sp. CS684. J. Microbiol., 45, 6-10.
153. Mimouni, M., Khardli, F.Z., Warad, I., Ahmad, M., Mubarak, M.S., Sultana, S., and Hadda, T.B. (2014) Antimicrobial activity of naturally occurring antibiotics monensin, lasalocid and their metal complexes. J. Mater. Environ. Sci., 5, 207-214.
154. Zhorova, R., Marina, M., Radeva, A., Mitewa, M., and Pantcheva, I. (2013) Cytotoxicity of monensic acid and its biometal(II) complexes against anaerobic bacterial strain Clostridium perfringens spp. Biotechnol. Biotechnol. Equip., 27, 4308-4310.
155. Huczyński, A., Domańska, A., Łowicki, D., Brzezinski, B., and Bartl, F. (2009) Structure of 1-naphthylmethyl ester of monensin A complexes with monovalent metal cations. J. Mol. Struct., 920, 414-423.
156. Huczyński, A., Janczak, J., and Brzezinski, B. (2012) Structure of 1:1 complex of 1-naphthylmethyl ester of monensin A with sodium perchlorate studied by X-ray, FT-IR and ab initio methods. J. Mol. Struct., 1030, 131-137.
157. Huczyński, A., Domańska, A., Paluch, I., Stefańska, J., Brzezinski, B., and Bartl, F. (2008) Synthesis of new semisynthetic dipodands and tripodands from naturally occurring polyether ionophores. Tetrahedron Lett., 49, 5572-5575.
158. Ebata, E., Kasahara, H., Sekine, K., and Inoue, Y. (1975) Lysocellin, a new polyether antibiotic. I. Isolation, purification, physico-chemical and biological properties. J. Antibiot. (Tokyo), 28, 118-121.
159. Funayama, S., Nozoe, S., Tronquet, C., Anraku, Y., Komiyama, K., and Omura, S. (1992) Isolation and structure of a new polyether antibiotic, octacyclomycin. J. Antibiot. (Tokyo), 45, 1686-1691.
160. Poli, F., Pancaldi, S., and Vannini, G.L. (1986) The effect of monensin on chitin synthesis in Candida albicans blastospores. Eur. J. Cell Biol., 42, 79-83.
161. Podila, G.K., Rosen, E., San Francisco, M.J.D., and Kolattukudy, P.E. (1995) Targeted secretion of cutinase in Fusarium solani f.sp. pisi and Colletotrichum gloeosporioides. Phytopathology, 85, 238-242.
162. Stringer, J.R., Beard, C.B., Miller, R.F., and Wakefield, A.E. (2002) A new name (Pneumocystis jiroveci) for Pneumocystis from humans. Emerg. Infect. Dis., 8, 891-896.
163. Goldman, E. and Green, L.H. (2008) Practical Handbook of Microbiology, 2nd edn, CRC Press, pp. 740-744.
164. Cirioni, O., Giacometti, A., Barchiesi, F., and Scalise, G. (1998) In-vitro activity of lytic peptides, inhibitors of ion transport systems and ionophorous antibiotics against Pneumocystis carinii. J. Antimicrob. Chemother., 42, 141-145.
165. Oz, H.S., Hughes, W.T., and Rehg, J.E. (1997) Efficacy of lasalocid against murine Pneumocystis carinii pneumonitis. Antimicrob. Agents Chemother., 41, 191-192.
166. Delfini, L.F. (1989) The first case of Plasmodium falciparum resistant to chloroquine treatment discovered in the Republic of Afghanistan. Trans. R. Soc. Trop. Med. Hyg., 83, 316.
167. Schapira, A., Beales, P.F., and Halloran, M.E. (1993) Malaria: living with drug resistance. Parasitol. Today, 9, 168-174.
168. Trape, J.F., Pison, G., Preziosi, M.P., Enel, C., Desgrees du Lou, A., Delaunay, V., Samb, B., Lagarde, E., Molez, J.F., and Simondon, F. (1998) Impact of chloroquine resistance on malaria mortality. C.R. Acad. Sci., Ser. III, 321, 689-697.
169. Gumila, C., Ancelin, M.L., Jeminet, G., Delort, A.M., Miquel, G., and Vial, H.J. (1996) Differential in vitro activities of ionophore compounds against Plasmodium falciparum and mammalian cells. Antimicrob. Agents Chemother., 40, 602-608.
170. Gumila, C., Ancelin, M.L., Delort, A.M., Jeminet, G., and Vial, H.J. (1997) Characterization of the potent in vitro and in vivo antimalarial activities of ionophore compounds. Antimicrob. Agents Chemother., 41, 523-529.
171. Adovelande, J. and Schrevel, J. (1996) Carboxylic ionophores in malaria chemotherapy: the effects of monensin and nigericin on Plasmodium falciparum in vitro and Plasmodium vinckei petteri in vivo. Life Sci., 59, 309-315.
172. Kevin, D.A. II, Meujo, D.A.F., and Hamann, M.T. (2009) Polyether ionophores: broad-spectrum and promising biologically active molecules for the control of drug-resistant bacteria and parasites. Expert Opin. Drug Discovery Opt., 4, 109-146.
173. Smith, C.K. and Strout, R.G. (1980) Eimeria tenella: effect of narasin, a polyether antibiotic on the ultrastructure of intracellular sporozoites. Exp. Parasitol., 50, 426-436.
174. Conway, D.P., Johnson, J.K., Guyonnet, V., Long, P.L., and Smothers, C.D. (1993) Efficacy of semduramicin and salinomycin against different stages of Eimeria tenella and E. acervulina in the chicken. Vet. Parasitol., 45, 215-229.
175. Cerruti Sola, S., Leoni, A., Agostini, A., and Castagnaro, M. (1996) Efficacy of maduramicin against turkey coccidiosis in battery: a clinical and pathological study. Schweiz. Arch. Tierheilkd., 138, 201-206.
176. Munir, K., Muneer, M.A., and Khan, M.Z. (1994) Immunomodulatory effects of salinomycin sodium in broiler chickens. Pakistan Vet. J., 14, 171-179.
177. Munir, K., Muneer, M.A., Tiwari, A., Chaudhry, R.M., and Muruganandan, S. (2007) Effects of polyether ionophores on the protective immune responses of broiler chickens against Angara disease and Newcastle disease viruses. Vet. Res. Commun., 31, 909-929.
178. Takahashi, Y., Nakamura, H., Ogata, R., Matsuda, N., Hamada, M., Naganawa, H., Takita, T., Sato, K., and Takeuchi, T. (1990) Kijimicin, a polyether antibiotic. J. Antibiot. (Tokyo), 43, 441-443.
179. Dirlam, J.P., Belton, A.M., Bordner, J., Cullen, W.P., Huang, L.H., Kojima, Y., Maeda, H., Nishiyama, S., Oscarson, J.R., Ricketts, A.P., Sakakibara, T., Tone, J., Tsukuda, K., and Yamada, M. (1992) CP-82, 009, a potent polyether anticoccidial related to septamycin and produced by Actinomadura. J. Antibiot., 45, 331-340.
180. Flanigan, T.P. (1994) Human immunodeficiency virus infection and cryptosporidiosis: protective immune responses. Am. J. Trop. Med. Hyg., 50, 29-35.
181. Euzeby, J. (2002) The epidemiology of human cryptosporidiosis. Bull. Acad. Natl. Med., 186, 837-850.
182. Fujikawa, H., Miyakawa, H., Iguchi, K., Nishizawa, M., Moro, K., Nagai, K., and Ishibashi, M. (2002) Intestinal cryptosporidiosis as an initial manifestation in a previously healthy Japanese patient with AIDS. J. Gastroenterol., 37, 840-843.
183. Lim, Y.A., Rohela, M., Sim, B.L., Jamaiah, I., and Nurbayah, M. (2005) Prevalence of cryptosporidiosis in HIVinfected patients in Kajang Hospital, Selangor. Southeast Asian J. Trop. Med. Public Health, 36, 30-33.
184. Fleck,W.F., Strauss, D.G., Meyer, J., and Porstendorfer, G. (1978) Fermentation, isolation, and biological activity of maduramycin: a new antibiotic from Actinomadura rubra. Z. Allg. Mikrobiol., 18, 389-398.
185. Tzipori, S.R., Campbell, I., and Angus, K.W. (1982) The therapeutic effect of 16 antimicrobial agents on Cryptosporidium infection in mice. Aust. J. Exp. Biol. Med. Sci., 60, 187-190.
186. Folz, S.D., Lee, B.L., Nowakowski, L.H., and Conder, G.A. (1988) Anticoccidial evaluation of halofuginone, lasalocid, maduramicin, monensin and salinomycin. Vet. Parasitol., 28, 1-9.
187. McDonald, V., Stables, R., Warhurst, D.C., Barer, M.R., Blewett, D.A., Chapman, H.D., Connolly, G.M., Chiodini, P.L., and McAdam, K.P.W.J. (1990) In vitro cultivation of Cryptosporidium parvum and screening for anticryptosporidial drugs. Antimicrob. Agents Chemother., 34, 1498-1500.
188. Blagburn, B.L., Sundermann, C.A., Lindsay, D.S., Hall, J.E., and Tidwell, R.R. (1991) Inhibition of Cryptosporidium parvum in neonatal Hsd:(ICR)BR Swiss miceby polyether ionophores and aromatic amidines. Antimicrob. Agents Chemother., 35, 1520-1523.
189. Mead, J.R., You, X., Pharr, J.E., Belenkaya, Y., Arrowood, M.J., Fallon, M.T., and Schinazi, R.F. (1995) Evaluation of maduramicin and alborixin in a SCID mouse model of chronic cryptosporidiosis. Antimicrob. Agents Chemother., 39, 854-858.
190. Woods, K.M., Nesterenko, M.V., and Upton, S.J. (1996) Efficacy of 101 antimicrobials and other agents on the development of Cryptosporidium parvum in vitro. Ann. Trop. Med. Parasitol., 90, 603-615.
191. You, X., Schinazi, R.F., Arrowood, M.J., Lejkowski, M., Juodawlkis, A.S., and Mead, J.R. (1998) In-vitro activities of paromomycin and lasalocid evaluated in combination against Cryptosporidium parvum. J. Antimicrob. Chemother., 41, 293-296.
192. Carrada-Bravo, T. (1983) Toxoplasmosis. A public health problem. Advances and perspective. Bol. Med. Hosp. Infant. Mex., 40, 353-362.
193. Soete, M., Fortier, B., Camus, D., and Dubremetz, J.F. (1993) Toxoplasma gondii: kinetics of bradyzoite-tachyzoite interconversion in vitro. Exp. Parasitol., 76, 259-264.
194. Wong, S.Y. and Remington, J.S. (1993) Biology of Toxoplasma gondii. Aids, 7, 299-316.
195. Ricketts, A.P. and Pfefferkorn, E.R. (1993) Toxoplasma gondii: susceptibility and development of resistance to anticoccidial drugs in vitro. Antimicrob. Agents Chemother., 37, 2358-2363.
196. Couzinet, S., Dubremetz, J.F., David, L., and Prensier, G. (1994) Toxoplasma gondii: activity of the polyether ionophorous antibiotic nigericin on tachyzoites in cell culture. Exp. Parasitol., 78, 341-351.
197. Couzinet, S., Dubremetz, J.F., Buzoni-Gatel, D., Jeminet, G., and Prensier, G. (2000) In vitro activity of the polyether ionophorous antibiotic monensin against the cyst form of Toxoplasma gondii. Parasitology, 12, 359-365.
198. Fruth, I.A. and Arrizabalaga, G. (2007) Toxoplasma gondii: induction of egress by the potassium ionophore nigericin. Int. J. Parasitol., 37, 1559-1567.
199. Parfenova, H., Haffner, J., and Leffler, C.W. (1999) Phosphorylation-dependent stimulation of prostanoid synthesis by nigericin in cerebral endothelial cells. Am. J. Physiol., 277, 728-738.
200. Mahmoudi, N., Garcia-Domenech, R., Galvez, J., Farhati, K., Franetich, J.F., Sauerwein, R., Hannoun, L., Derouin, F., Danis, M., and Mazier, D. (2008) New active drugs against liver stages of Plasmodium predicted by molecular topology. Antimicrob. Agents Chemother., 52, 1215-1220.
201. Oh, J.H., O'Malley, K.L., Krajewski, S., Reed, J.C., and Oh, Y.J. (1997) Bax accelerates staurosporine-induced but suppresses nigericin-induced neuronal cell death. Neuroreport, 27, 1851-1856.
202. Lindsay, D.S., Rippey, N.S., Cole, R.A., Parsons, L.C., Dubey, J.P., Tidwell, R.R., and Blagburn, B.L. (1994) Examination of the activities of 43 chemotherapeutic agents against Neospora caninum tachyzoites in cultured cells. Am. J. Vet. Res., 55, 976-981.
203. Pal, R., Gallo, R.C., and Sarngadharan, M.G. (1988) Processing of the structural proteins of human immunodeficiency virus type 1 in the presence of monensin and cerulenin. Proc. Natl. Acad. Sci. U.S.A., 85, 9283-9286.
204. Dewar, R.L., Vasudevachari, M.B., Natarajan, V., and Salzman, N.P. (1989) Biosynthesis and processing of human immunodeficiency virus type 1 envelope glycoproteins: Effects of monensin on glycosylation and transport. J. Virol., 63, 2452-2456.
205. Nakamura, M., Ohno, T., Kunimoto, S., Naganawa, H., and Takeuchi, T. (1991) Kijimicin: an inhibitor of human immunodeficiency virus in acutely and chronically infected cells. J. Antibiot. (Tokyo), 44, 569-571.
206. Nakamura, M., Kunimoto, S., Takahashi, Y., Naganawa, H., Sakaue, M., Inoue, S., Ohno, T., and Takeuchi, T. (1992) Inhibitory effects of polyethers on human immunodeficiency virus replication. Antimicrob. Agents Chemother., 36, 492-494.
207. Yamauchi, T., Nakamura, M., Honma, H., Ikeda, M., Kawashima, K., and Ohno, T. (1993) Mechanistic effects of kijimicin on inhibition of human immunodeficiency virus replication. Mol. Cell. Biochem., 119, 35-41.
208. World Health Organization http://www.who.int/mediacentre/factsheets/fs297/en/ (accessed 21 February 2014).
209. Statkiewicz, M. and Małecki, M. (2009) Macierzyste komórki nowotworowe, a oporność nowotworów na terapiȩ. Nowotwory J. Oncol., 59, 456-463.
210. Park, W.H., Seol, J.G., Kim, E.S., Kang, W.K., Im, Y.H., Jung, C.W., Kim, B.K., and Lee, Y.Y. (2002) Monensinmediated growth inhibition in human lymphoma cells through cell cycle arrest and apoptosis. Br. J. Haematol., 119, 400-407.
211. Park, W.H., Kim, E.S., Kim, B.K., and Lee, Y.Y. (2003) Monensin-mediated growth inhibition in NCI-H929 myeloma cells via cell cycle arrest and apoptosis. Int. J. Oncol., 23, 197-204.
212. Park, W.H., Kim, E.S., Jung, C.W., Kim, B.K., and Lee, Y.Y. (2003) Monensinmediated growth inhibition of SNU-C1 colon cancer cells via cell cycle and apoptosis. Int. J. Oncol., 22, 377-382.
213. Sehested, M., Skovsgaard, T., and Roed, H. (1988) The carboxylic ionophore monensin inhibits active drug efflux and modulates in vitro resistance in daunorubicin resistant Ehrlich ascites tumor cells. Biochem. Pharmacol., 37, 3305-3310.
214. Colombatti, M., Dell'Arciprete, L., Chignola, R., and Tridente, G. (1990) Carrier protein-monensin conjugates:enhancement of immunotoxin cytotoxicity and potential in tumor treatment. Cancer Res., 50, 1385-1391.
215. Derbyshire, E.J., Henry, R.V., Stahel, R.A., and Wawrzynczak, E.J. (1992) Potent cytotoxic action of the immunotoxin SWA11-ricin A chain against human small cell lung cancer cell lines. Br. J. Cancer, 66, 444-451.
216. Ling, Y., Priebe, W., and Perezsoler, R. (1993) Intrinsic cytotoxicity and reversal of multidrug-resistance by monensin in KB parent and MDR cells. Int. J. Oncol., 3, 971-977.
217. Wood, D.J., Rumsby, M.G., and Warr, J.R. (1996) Monensin and verapamil do not alter intracellular localization of daunorubicin in multidrug resistant human KB cells. Cancer Lett., 108, 41-47.
218. Newton, D.L., Hansen, H.J., Mikulski, S.M., Goldenberg, D.M., and Rybak, S.M. (2001) Potent and specific antitumor effects of an anti-CD22-targeted cytotoxic ribonuclease: potential for the treatment of non-Hodgkin lymphoma. Blood, 97, 528-535.
219. Singh, M., Ferdous, A.J., and Jackson, T.L. (1999) Stealth monensin liposomes as a potentiator of adriamycin in cancer treatment. J. Controlled Release, 59, 43-53.
220. Singh, M., Ferdous, A.J., Kanikkannan, N., and Faulkner, G. (2001) Stealth monensin immunoliposomes as potentiator of immunotoxins in vitro. Eur. J. Pharm. Biopharm., 52, 13-20.
221. Shaik, M.S., Jackson, T.L., and Singh, M. (2003) Effect of monensin liposomes on the cytotoxicity of anti-My9-bR immunotoxin. J. Pharm. Pharmacol., 55, 819-825.
222. Shaik, M.S., Chatterjee, A., and Singh, M. (2004) Effects of monensin liposomes on the cytotoxicity, apoptosis and expression of multidrug resistance genes in doxorubicin-resistant human breast tumour (MCF-7/dox) cell-line. J. Pharm. Pharmacol., 56, 899-907.
223. Griffin, T., Rybak, M.E., Recht, L., Singh, M., Salimi, A., and Raso, V. (1993) Potentiation of antitumor immunotoxins by liposomal monensin. J. Natl. Cancer Inst., 85, 292-298.
224. Ketola, K., Vainio, P., Fey, V., Kallioniemi, O., and Iljin, K. (2010) Monensin is a potent inducer of oxidative stress and inhibitor of androgen signaling leading to apoptosis in prostate cancer cells. Mol. Cancer Ther., 9, 3175-3185.
225. Gupta, P.B., Onder, T.T., Jiang, G., Tao, K., Kuperwasser, C., Weinberg, R.A., and Lander, E.S. (2009) Identification of selective inhibitors of cancer stem cells by high-throughput screening. Cell, 138, 645-659.
226. Naujokat, C., Fuchs, D., and Opelz, G. (2010) Salinomycin in cancer: a new mission for an old agent. Mol. Med. Rep., 3, 555-559.
227. Fuchs, D., Heinold, A., Opelz, G., Daniel, V., and Naujokat, C. (2009) Salinomycin induces apoptosis and overcomes apoptosis resistance in human cancer cells. Biochem. Biophys. Res. Commun., 390, 743-749.
228. Riccioni, R., Dupuis, M.L., Bernabei, M., Petrucci, E., Pasquini, L., Mariani, G., Cianfriglia, M., and Testa, U. (2010) The cancer stem cell selective inhibitor salinomycin is a p-glycoprotein inhibitor. Blood Cells Mol. Dis., 45, 86-92.
229. Fuchs, D., Daniel, V., Sadeghi, M., Opelz, G., and Naujokat, C. (2010) Salinomycin overcomes ABC transportermediated multidrug and apoptosis resistance in human leukemia stem cell-like KG-1a cells. Biochem. Biophys. Res. Commun., 394, 1098-1104.
230. Lepper, E.R., Nooter, K., Verweij, J., Acharya, M.R., Figg, W.D., and Sparreboom, A. (2005) Mechanisms of resistance to anticancer drugs: the role of the polymorphic ABC transporters ABCB1 and ABCG2. Pharmacogenomics, 6, 115-138.
231. Tiwari, A.K., Sodani, K., Dai, C.L., Ashby, C.R., and Chen, Z.S. (2011) Revisiting the ABCs of multidrug resistance in cancer chemotherapy. Curr. Pharm. Biotechnol., 12, 570-594.
232. Lee, C.H. (2010) Reversing agents for ATP-binding cassette drug transporters. Methods Mol. Biol., 596, 325-340.
233. Lu, D., Choi, M.Y., Yu, J., Castro, J.E., Kipps, T.J., and Carson, D.A. (2011) Salinomycin inhibits Wnt signaling and selectively induces apoptosis in chronic lymphocytic leukemia cells. Proc. Natl. Acad. Sci. U.S.A., 108, 13253-13257.
234. Reya, T. and Clevers, H. (2005) Wnt signaling in stem cells and cancer. Nature, 434, 843-850.
235. Wang, Y. (2011) Effects of Salinomycin on cancer stem cell in human lung adenocarcinoma A549 cells. Med. Chem., 7, 106-111.
236. Arafat, K., Iratni, R., Takahashi, T., Parek, K., Al Dhaheri, Y., Adrian, T.E., and Attoub, S. (2013) Inhibitory effects of salinomycin on cell survival, colony growth, migration, and invasion of human non-small cell lung cancer A549 and LNM35: involvement of NAG-1. PLoS One, 8, article number: e66931.
237. Dong, T.T., Zhou, H.M., Wang, L.L., Feng, B., Lv, B., and Zheng, M.H. (2011) Salinomycin selectively targets 'CD133+' cell subpopulations and decreases malignant traits in colorectal cancer lines. Ann. Surg. Oncol., 18, 1797-1804.
238. Kim, K.Y., Yu, S.N., Lee, S.Y., Chun, S.S., Choi, Y.L., Park, Y.M., Song, C.S., Chatterjee, B., and Ahn, S.C. (2011) Salinomycin-induced apoptosis of human prostate cancer cells due to accumulated reactive oxygen species and mitochondrial membrane depolarization. Biochem. Biophys. Res. Commun., 413, 80-86.
239. Kim, W.K., Kim, J.H., Yoon, K., Kim, S., Ro, J., Kang, H.S., and Yoon, S. (2012) Salinomycin, a p-glycoprotein inhibitor, sensitizes radiation-treated cancer cells by increasing DNA damage and inducing G2 arrest. Invest. New Drugs, 30, 1311-1318.
240. Park, S.H., Wang, X., Liu, R., Lam, K.S., and Weiss, R.H. (2008) High throughput screening of a small molecule one-bead-one-compound combinatorial library to identify attenuators of p21 as chemotherapy sensitizers. Cancer Biol. Ther., 7, 2015-2022.
241. Idogawa, M., Sasaki, Y., Suzuki, H., Mita, H., Imai, K., Shinomura, Y., and Tokino, T. (2009) A single recombinant adenovirus expressing p53 and p21-targeting artificial microRNAs efficiently induces apoptosis in human cancer cells. Clin. Cancer Res., 15, 3725-3732.
242. Kim, J.H., Chae, M.J., Kim, W.K., Kim, Y.J., Kang, H.S., Kim, H.S., and Yoon, S. (2011) Salinomycin sensitizes cancer cells to the effects of doxorubicin and etoposide treatment by increasing DNA damage and reducing p21 protein. Br. J. Pharmacol., 162, 773-784.
243. Zhi, Q.M., Chen, X.H., Ji, J., Zhang, J.N., Li, J.F., Cai, Q., Liu, B.Y., Gu, Q.L., Zhu, Z.G., and Yu, Y.Y. (2011) Salinomycin can effectively kill ALDH(high) stem-like cells on gastric cancer. Biomed. Pharmacother., 65, 509-515.
244. Kim, J.H., Yoo, H.I., Kang, H.S., Ro, J., and Yoon, S. (2012) Salinomycin sensitizes antimitotic drugs-treated cancer cells by increasing apoptosis via the prevention of G2 arrest. Biochem. Biophys. Res. Commun., 418, 98-103.
245. Zhang, G.N., Liang, Y., Zhou, L.J., Chen, S.P., Chen, G., Zhang, T.P., Kang, T., and Zhao, Y.P. (2011) Combination of salinomycin and gemcitabine eliminates pancreatic cancer cells. Cancer Lett., 313, 137-144.
246. Wu, D., Zhang, Y., Huang, J., Fan, Z., Shi, F., and Wang, S. (2013) Salinomycin inhibits proliferation and induces apoptosis of human nasopharyngeal carcinoma cell in vitro and suppresses tumor growth in vivo. Biochem. Biophys. Res. Commun., 443, 712-717.
247. Kusunoki, S., Kato, K., Tabu, K., Inagaki, T., Okabe, H., Kaneda, H., Suga, S., Terao, Y., Taga, T., and Takeda, S. (2013) The inhibitory effect of salinomycin on the proliferation, migration as well as invasion of human endometrial cancer stem-like cells. Gynecol. Oncol., 129, 598-605.
248. Al. Dhaheri, Y., Attoub, S., Arafat, K., Abuqamar, S., Eid, A., Al. Faresi, N., and Iratni, R. (2013) Salinomycin induces apoptosis and senescence in breast cancer: Upregulation of p21, downregulation of surviving and histone H3 and H4 hyperacetylation. Biochim. Biophys. Acta, Gen. Subj., 1830, 3121-3135.
249. Wang, F., He, L., Dai, W.Q., Xu, Y.P., Wu, D., Lin, C.L., Wu, S.M., Cheng, P., Zhang, Y., Shen, M., Wang, C.F., Lu, J., Zhou, Y.Q., Xu, X.F., Xu, L., and Guo, C.Y. (2012) Salinomycin inhibits proliferation and induces apoptosis of human hepatocellular carcinoma cells in vitro and in vivo. PLoS ONE, 7, article number: e50638.
250. He, L.,Wang, F., Dai,W.Q., Wu, D., Lin, C.L., Wu, S.M., Cheng, P., Zhang, Y., Shen, M., Wang, C.F., Lu, J., Zhou, Y.Q., Xu, X.F., Xu, L., and Guo, C.Y. (2013) Mechanism of action of salinomycin on growth and migration in pancreatic cancer cell lines. Pancreatology, 13, 72-78.
251. Zhou, J., Li, P., Xue, X., He, S., Kuang, Y., Zhao, H., Chen, S., Zhi, Q., and Guo, X. (2013) Salinomycin induces apoptosis in cisplatin-resistant colorectal cancer cells by accumulation of reactive oxygen species. Toxicol. Lett., 222, 139-145.
252. Parajuli, B., Lee, H.G., Kwon, S.H., Cha, S.D., Shin, S.J., Lee, G.H., Bae, I., and Cho, C.H. (2013) Salinomycin inhibits Akt/NF-KB and induces apoptosis in cisplatin resistant ovarian cancer cells. Cancer Epidemiol., 37, 512-517.
253. Zhang, B., Wang, X., Cai, F., Chen, W., Loesch, U., and Zhong, X.Y. (2013) Antitumor properties of salinomycin on cisplatin-resistant human ovarian cancer cells in vitro and in vivo:involvement of p38 MAPK activation. Oncol. Rep., 29, 1371-1378.
254. Huczyński, A. (2012) Salinomycin - a new cancer drug candidate. Chem. Biol. Drug Des., 79, 235-238.
255. Li, T., Su, L., Zhong, N., Hao, X., Zhong, D., Singhal, S., and Liu, X. (2013) Salinomycin induces cell death with autophagy through activation of endoplasmic reticulum stress in human cancer cells. Autophagy, 9, 1057-1068.
256. Naujokat, C. and Steinhart, R. (2012) Salinomycin as a drug for targeting human cancer stem cells. J. Biomed. Biotechnol., 2012, 950658, 17 pp.
257. Momekova, D., Momekov, G., Ivanova, J., Pantcheva, I., Drakalska, E., Stoyanov, N., Guenova, M., Michova, A., Balashev, K., Arpadjan, S., Mitewa, M., Rangelov, S., and Lambov, N. (2013) Sterically stabilized liposomes as a platform for salinomycin metal coordination compounds: physicochemical characterization and in vitro evaluation. J. Drug Delivery Sci. Technol., 23, 215-223.